Brachytherapy for oligometastatic prostate cancer to the penis.
Fiche publication
Date publication
octobre 2021
Journal
Journal of contemporary brachytherapy
Auteurs
Membres identifiés du Cancéropôle Est :
Dr MARTZ Nicolas
Tous les auteurs :
Martz N, Benziane-Ouaritini N, Gautier M, Brenot-Rossi I, Montagne L, Salem N, Bodokh Y, Hannoun-Levi JM
Lien Pubmed
Résumé
The origin of penile metastases is in 70% of cases from primary pelvic cancers (genitourinary and recto-sigmoid primary tumors). The prognosis is poor and it is often associated with synchronous bone metastases at the time of diagnosis. We present the case of a 61-year-old patient who developed a penile induration 7 years after radical prostatectomy followed by adjuvant external beam radiation therapy for high-risk prostatic adenocarcinoma. Biopsies confirmed the metastatic localization and a detailed assessment failed to find any further remote lesions. Faced with this penile oligometastatic prostate cancer, we proposed an ablative treatment based on interstitial multi-catheter high-dose rate brachytherapy. At the six-month follow-up, clinical examination and Ga-PSMA-11-PET confirmed a complete response of the penile tumor without new lesion at a distance.
Mots clés
brachytherapy, oligometastasis, penile cancer, prostate cancer
Référence
J Contemp Brachytherapy. 2021 10;13(5):593-597